Zobrazeno 1 - 10
of 75
pro vyhledávání: '"F. K. Port"'
Autor:
F. Locatelli, G. Choukroun, D. Fliser, J. Moecks, A. Wiggenhauser, A. Gupta, D. W. Swinkels, V. Lin, C. Guss, R. Pratt, P. Carrilho, A. R. Martins, M. Alves, A. Mateus, L. Gusmao, L. Parreira, J. Assuncao, I. Rodrigues, D. Stamopoulos, N. Mpakirtzi, N. Afentakis, E. Grapsa, E. Zitt, G. Sturm, F. Kronenberg, U. Neyer, F. Knoll, K. Lhotta, G. Weiss, B. M. Robinson, M. Larkina, B. Bieber, W. Kleophas, Y. Li, K. McCullough, J. G. Nolen, F. K. Port, R. L. Pisoni, R. M. Kalicki, D. E. Uehlinger, C. Ogawa, F. Kanda, N. Tomosugi, T. Maeda, T. Kuji, T. Fujikawa, M. Shino, K. Shibata, T. Kaneda, M. Nishihara, H. Satta, S.-I. Kawata, N. Koguchi, K. Tamura, N. Hirawa, Y. Toya, S. Umemura, J. Chanliau, H. Martin, K. Stamatelou, L. Gonzalez-Tabares, N. Manamley, M. Farouk, J. Addison, J. Donck, A. Schneider, L. Gutjahr-Lengsfeld, E. Ritz, H. Scharnagl, G. Gelbrich, S. Pilz, I. C. Macdougall, C. Wanner, C. Drechsler, V. Kuntsevich, E. Charen, D. Kobena, N. Sheth, H. Siktel, N. W. Levin, J. F. Winchester, P. Kotanko, G. Kaysen, T. Kuragano, A. Kida, M. Yahiro, M. Nanami, Y. Nagasawa, Y. Hasuike, T. Nakanishi, V. Dimitratou, I. Griveas, E. Lianos, Y. Sasaki, S. Yamazaki, K. Fujita, M. Kurasawa, K. Yorozu, Y. Shimonaka, N. Suzuki, M. Yamamoto, R. Zwiech, J. Szczepa ska, A. Bruzda-Zwiech, A. Rao, J. Gilg, F. Caskey, A. Kirkpantur, M. M. Balci, A. Turkvatan, B. Afsar, M. Alkis, F. Mandiroglu, Y. O. Kim, S. A. Yoon, Y. S. Kim, S. J. Choi, J. W. Min, M. A. Cheong, M. Oue, K. Yamamoto, T. Kimura, W. Fukao, S. Kaibe, P. S. Djuric, J. Ikonomovski, J. Tosic, A. Jankovic, Z. Majster, V. Stankovic Popovic, N. Dimkovic, V. Aicardi Spalloni, L. Del Vecchio, S. Longhi, L. Violo, V. La Milia, G. Pontoriero, I. Macdougall, A. Rumjon, E. Mangahis, L. Goldstein, T. Ryzlewicz, F. Becker, W. Kilgallon, M. Fukasawa, Y. Otake, T. Yamagishi, M. Kamiyama, H. Kobayashi, M. Takeda, T. Toida, Y. Sato, S. Fujimoto
Publikováno v:
Nephrology Dialysis Transplantation. 29:iii491-iii500
Publikováno v:
Nieren- und Hochdruckkrankheiten. 42:532-538
Autor:
V. Wizemann, P. Wabel, Marcus D. Säemann, M. Antlanger, F. K. Port, Manfred Hecking, Walter H. Hörl, Gere Sunder-Plassmann
Publikováno v:
Nieren- und Hochdruckkrankheiten. 42:353-358
Autor:
Werner Kleophas, H. Reichel, Bruce M. Robinson, G. Lonnemann, F. K. Port, R. L. Pisoni, Danilo Fliser, Lars Christian Rump, J. Duttlinger, B. Bieber
Publikováno v:
Nieren- und Hochdruckkrankheiten. 42:251-259
Autor:
R. L. Pisoni, J. L. Bragg-Gresham, Werner Kleophas, F. K. Port, Jürgen Bommer, M. A. Eichleay
Publikováno v:
Nieren- und Hochdruckkrankheiten. 37:545-554
Autor:
Marshall M. Joffe, Ronald L. Pisoni, F. K. Port, Jeffrey S. Berns, Harold I. Feldman, Bruce M. Robinson
Publikováno v:
Kidney International. 68:2323-2330
Anemia and mortality in hemodialysis patients: Accounting for morbidity and treatment variables updated over time.BackgroundThe objective of this study was to gain insight into the associations of anemia with mortality among maintenance hemodialysis
Autor:
F. K. Port
Publikováno v:
JAMA: The Journal of the American Medical Association. 270:1339-1343
Publikováno v:
American Journal of Public Health. 80:153-157
We conducted a case-control study of 325 men ages 30-69 who were diagnosed with end-stage renal disease (ESRD) between 1976 and 1984, and resided in four urban areas of Michigan in 1984. Cases were selected from the Michigan Kidney Registry and exclu
Publikováno v:
Nefrologia : publicacion oficial de la Sociedad Espanola Nefrologia. 27(4)
The increased mortality risk in hemodialysis (HD) patients unable to meet six targets in different areas of HD practice has been reported previously. Using a prevalent cross-sectional sample of Spanish HD patients (n = 613) from the second stage of t
Autor:
G, Pontoriero, F, Locatelli, V E, Andreucci, J, Bragg-Gresham, M A, Eichleavy, R L, Pisoni, F K, Port
Publikováno v:
Giornale italiano di nefrologia : organo ufficiale della Societa italiana di nefrologia. 24(3)
Knowing the relative risk (RR) of mortality associated with being outside the guideline targets and the percentage of patients in this situation, it is possible to estimate the number of patient life years that could be gained from adhering to guidel